Pilaralisib analogue

Overview

Pilaralisib analogue is a Class 1 phosphatidylinositol 3 kinase (PI3K) family inhibitor. It is an orally bioavailable small molecule, targeting the class I PI3K family of lipid kinases. It has potential antineoplastic activity. It binds to class 1 PI3Ks in an ATP-competitive manner by inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3) and the activation of the PI3K signaling pathway.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | PI3K

Product Information

• Catalog No.: B0084-258924
• CAS No.: 956958-53-5
• Molecular Formula: C21H16N6O2S2
• Molecular Weight: 448.52
• Purity: >99%
• Storage: -20°C Freezer
• Solubility: DMSO ≥ 86 mg/mL, Water < 1.2 mg/mL, Ethanol < 1.2 mg/mL

Source

Original product source